Related Experiment Video

Updated: Feb 20, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.7K

RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions

Barbara J Page1,2, Rayleen V Bowman1,2, Ian A Yang1,2

  • 1Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, Queensland, Australia.

Journal of the National Cancer Institute
|October 19, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
07:53

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Published on: March 17, 2020

7.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.0K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.0K

Articles linked to this work by shared authors, journal, and citation graph.

Descriptive analysis of screen-detected versus clinically diagnosed lung cancer cases: evidence of earlier stage shift and treatment differences.

Internal medicine journal·2026

Vertebral computed tomography attenuation to case-find low bone density in people undergoing lung cancer screening.

The British journal of radiology·2026

Interventions for smoking cessation in people undergoing lung cancer screening.

The Cochrane database of systematic reviews·2026

Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.

Cell reports. Medicine·2026

Comparative Liquid Biopsy Testing for KRAS Mutations From Plasma Cell-Free DNA (cfDNA) and Extracellular Vesicles in Lung Adenocarcinoma.

Cancer reports (Hoboken, N.J.)·2026

Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients.

ERJ open research·2026

Lifestyle and genetic risk factors for postmenopausal breast cancer in the multiethnic cohort.

Journal of the National Cancer Institute·2026

Trends in incidence rates of uterine corpus cancer by birth cohort in 24 countries, 1998-2017.

Journal of the National Cancer Institute·2026

Associations between breast cancer and rheumatoid arthritis among older-age women in the United States.

Journal of the National Cancer Institute·2026

NCI's clinical assay development program: supporting translation of biomarkers for cancer diagnosis.

Journal of the National Cancer Institute·2026

Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma.

Journal of the National Cancer Institute·2026

Trends in bone health agent use and skeletal events in metastatic castration-resistant prostate cancer.

Journal of the National Cancer Institute·2026

Diagnostic Discordance in a 46,XX Ovarian Dissecting Gonadoblastoma with Dysgerminoma Transformation and Leydig Cell Tumor: Hyperandrogenism, β-hCG Elevation, and CEUS Findings.

Diagnostics (Basel, Switzerland)·2026

Recurrent Mesonephric-like Adenocarcinoma of the Ovary with Bladder and Vaginal Recurrences: A Diagnostic Challenge.

Diagnostics (Basel, Switzerland)·2026

Silent Ovary with a Loud Hormonal Signal: A Case Report and Literature Review of an Androgen-Secreting Stromal Luteoma.

Journal of clinical medicine·2026

Sporadic ampullary adenoma mimicking adenocarcinoma in the absence of genetic predisposition: a case report.

Journal of surgical case reports·2026

Real-world management of ovarian cancer in women living with HIV: treatment exposure, immune monitoring, and care barriers in a five-case series.

Frontiers in oncology·2026

Lower proportion of bladder cancer diagnosed at unscheduled hospitalization after introduction of standardized care pathways in Sweden.

Scandinavian journal of urology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us